516 related articles for article (PubMed ID: 8543841)
1. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage.
Finnegan A; Roebuck KA; Nakai BE; Gu DS; Rabbi MF; Song S; Landay AL
J Immunol; 1996 Jan; 156(2):841-51. PubMed ID: 8543841
[TBL] [Abstract][Full Text] [Related]
2. IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage.
Weissman D; Poli G; Fauci AS
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(5):442-9. PubMed ID: 7627621
[TBL] [Abstract][Full Text] [Related]
3. Modulation of endogenous IL-1 beta and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells.
Goletti D; Kinter AL; Hardy EC; Poli G; Fauci AS
J Immunol; 1996 May; 156(9):3501-8. PubMed ID: 8617979
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 enhances human immunodeficiency virus type 1 expression in a chronically infected promonocytic cell line (U1) by a tumor necrosis factor alpha-independent mechanism.
Angel JB; Saget BM; Wang MZ; Wang A; Dinarello CA; Skolnik PR
J Interferon Cytokine Res; 1995 Jun; 15(6):575-84. PubMed ID: 7553227
[TBL] [Abstract][Full Text] [Related]
5. cAMP stimulates human immunodeficiency virus (HIV-1) from latently infected cells of monocyte-macrophage lineage: synergism with TNF-alpha.
Chowdhury MI; Koyanagi Y; Horiuchi S; Hazeki O; Ui M; Kitano K; Golde DW; Takada K; Yamamoto N
Virology; 1993 May; 194(1):345-9. PubMed ID: 7683159
[TBL] [Abstract][Full Text] [Related]
6. The cAMP-dependent protein kinase A and protein kinase C-beta pathways synergistically interact to activate HIV-1 transcription in latently infected cells of monocyte/macrophage lineage.
Rabbi MF; al-Harthi L; Saifuddin M; Roebuck KA
Virology; 1998 Jun; 245(2):257-69. PubMed ID: 9636365
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells.
Rabbi MF; Finnegan A; Al-Harthi L; Song S; Roebuck KA
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):321-31. PubMed ID: 9833740
[TBL] [Abstract][Full Text] [Related]
8. Alpha-melanocyte-stimulating hormone peptides inhibit HIV-1 expression in chronically infected promonocytic U1 cells and in acutely infected monocytes.
Barcellini W; Colombo G; La Maestra L; Clerici G; Garofalo L; Brini AT; Lipton JM; Catania A
J Leukoc Biol; 2000 Nov; 68(5):693-9. PubMed ID: 11073109
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
Popik W; Pitha PM
Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218
[TBL] [Abstract][Full Text] [Related]
10. TNFalpha cooperates with the protein kinase A pathway to synergistically increase HIV-1 LTR transcription via downstream TRE-like cAMP response elements.
Rabbi MF; Al-Harthi L; Roebuck KA
Virology; 1997 Oct; 237(2):422-9. PubMed ID: 9356353
[TBL] [Abstract][Full Text] [Related]
11. The state of maturation of monocytes into macrophages determines the effects of IL-4 and IL-13 on HIV replication.
Naif HM; Li S; Ho-Shon M; Mathijs JM; Williamson P; Cunningham AL
J Immunol; 1997 Jan; 158(1):501-11. PubMed ID: 8977228
[TBL] [Abstract][Full Text] [Related]
12. Triggering of complement receptors CR1 (CD35) and CR3 (CD11b/CD18) induces nuclear translocation of NF-kappa B (p50/p65) in human monocytes and enhances viral replication in HIV-infected monocytic cells.
Thieblemont N; Haeffner-Cavaillon N; Haeffner A; Cholley B; Weiss L; Kazatchkine MD
J Immunol; 1995 Nov; 155(10):4861-7. PubMed ID: 7594489
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 and glucocorticoids synergistically induce human immunodeficiency virus type-1 expression in chronically infected U1 cells by a long terminal repeat independent post-transcriptional mechanism.
Kinter AL; Biswas P; Alfano M; Justement JS; Mantelli B; Rizzi C; Gatti AR; Vicenzi E; Bressler P; Poli G
Mol Med; 2001 Oct; 7(10):668-78. PubMed ID: 11713366
[TBL] [Abstract][Full Text] [Related]
14. NF-kappa B-dependent and -independent pathways of HIV activation in a chronically infected T cell line.
Antoni BA; Rabson AB; Kinter A; Bodkin M; Poli G
Virology; 1994 Aug; 202(2):684-94. PubMed ID: 7913275
[TBL] [Abstract][Full Text] [Related]
15. Dioxin activates human immunodeficiency virus-1 expression in chronically infected promonocytic U1 cells by enhancing NF-kappa B activity and production of tumor necrosis factor-alpha.
Gollapudi S; Kim CH; Patel A; Sindhu R; Gupta S
Biochem Biophys Res Commun; 1996 Sep; 226(3):889-94. PubMed ID: 8831706
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of NO production in macrophages by IL-13 is counteracted by Herpes simplex virus infection through tumor necrosis factor-alpha-induced activation of NK-kappa B.
Paludan SR; Ellermann-Eriksen S; Malmgaard L; Mogensen SC
Eur Cytokine Netw; 2000 Jun; 11(2):275-82. PubMed ID: 10903807
[TBL] [Abstract][Full Text] [Related]
17. Heat shock induction of HIV production from chronically infected promonocytic and T cell lines.
Stanley SK; Bressler PB; Poli G; Fauci AS
J Immunol; 1990 Aug; 145(4):1120-6. PubMed ID: 1696294
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of E3330, a novel quinone derivative able to suppress tumor necrosis factor-alpha generation, on activation of nuclear factor-kappa B.
Goto M; Yamada K; Katayama K; Tanaka I
Mol Pharmacol; 1996 May; 49(5):860-73. PubMed ID: 8622636
[TBL] [Abstract][Full Text] [Related]
19. Activation of cytokine genes in HIV-1 infected myelomonoblastic cells by phorbol ester and tumor necrosis factor.
D'Addario M; Wainberg MA; Hiscott J
J Immunol; 1992 Feb; 148(4):1222-9. PubMed ID: 1371135
[TBL] [Abstract][Full Text] [Related]
20. Signaling through the lymphotoxin-beta receptor stimulates HIV-1 replication alone and in cooperation with soluble or membrane-bound TNF-alpha.
Marshall WL; Brinkman BM; Ambrose CM; Pesavento PA; Uglialoro AM; Teng E; Finberg RW; Browning JL; Goldfeld AE
J Immunol; 1999 May; 162(10):6016-23. PubMed ID: 10229841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
